We are live on ! Find out more
WF

Welch & Forbes Portfolio holdings

AUM $8.23B
1-Year Est. Return 17.62%
This Fund
S&P 500
This Quarter Est. Return
+8.91%
1 Year Est. Return
+17.62%
3 Year Est. Return
+73.71%
5 Year Est. Return
+105.59%
10 Year Est. Return
+384.92%
AUM
$5.92B
AUM Growth
+$503M
Cap. Flow
+$69.9M
Cap. Flow %
1.18%
Top 10 Hldgs %
29.01%
Holding
402
New
16
Increased
142
Reduced
136
Closed
14

Top Buys

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$6.88M
2
PYPL icon
PayPal
PYPL
+$5.36M
3
AJG icon
Arthur J. Gallagher & Co
AJG
+$4.08M
4
TJX icon
TJX Companies
TJX
+$3.67M
5
AAPL icon
Apple
AAPL
+$2.77M

Top Sells

Rank Stock Value
1
MRK icon
Merck
MRK
+$2.32M
2
T icon
AT&T
T
+$1.94M
3
VAR
Varian Medical Systems, Inc.
VAR
+$1.8M
4
NVDA icon
NVIDIA
NVDA
+$1.7M
5
CVGW
Calavo Growers
CVGW
+$1.21M

Sector Composition

Rank Sector Weight
1 Technology 22.57%
2 Healthcare 20.34%
3 Consumer Discretionary 12.09%
4 Financials 11.37%
5 Industrials 8.19%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HON icon
151
Honeywell
HON
$76.7B
$3.2M 0.05%
15,490
+499
+3% +$105K
IJH icon
152
iShares Core S&P Mid-Cap ETF
IJH
$122B
$3.14M 0.05%
58,355
+8,185
+16% +$442K
NOC icon
153
Northrop Grumman
NOC
$76B
$3.07M 0.05%
8,458
-11
-0.1% -$3.96K
TFC icon
154
Truist Financial
TFC
$63.5B
$2.97M 0.05%
53,527
-315
-0.6% -$18.5K
SDY icon
155
State Street SPDR S&P Dividend ETF
SDY
$21.8B
$2.95M 0.05%
24,152
-212
-0.9% -$26.2K
GILD icon
156
Gilead Sciences
GILD
$163B
$2.92M 0.05%
42,372
-455
-1% -$30.4K
EEM icon
157
iShares MSCI Emerging Markets ETF
EEM
$28.6B
$2.88M 0.05%
52,173
+166
+0.3% +$9.02K
LMT icon
158
Lockheed Martin
LMT
$132B
$2.87M 0.05%
7,575
-284
-4% -$109K
LNT icon
159
Alliant Energy
LNT
$18.3B
$2.83M 0.05%
50,664
ZBH icon
160
Zimmer Biomet
ZBH
$18.4B
$2.73M 0.05%
17,518
-62
-0.4% -$10K
CRM icon
161
Salesforce
CRM
$148B
$2.73M 0.05%
11,177
+5,082
+83% +$1.17M
VWO icon
162
Vanguard FTSE Emerging Markets ETF
VWO
$119B
$2.67M 0.05%
49,130
-4,634
-9% -$247K
VLO icon
163
Valero Energy
VLO
$92.6B
$2.57M 0.04%
32,957
-3,365
-9% -$261K
NWL icon
164
Newell Brands
NWL
$2.18B
$2.5M 0.04%
90,947
-11,100
-11% -$306K
VRSK icon
165
Verisk Analytics
VRSK
$26.1B
$2.44M 0.04%
13,944
+3,909
+39% +$693K
SHOP icon
166
Shopify
SHOP
$159B
$2.38M 0.04%
16,320
+4,600
+39% +$567K
PM icon
167
Philip Morris
PM
$299B
$2.29M 0.04%
23,133
-976
-4% -$93.6K
CI icon
168
Cigna
CI
$76.1B
$2.22M 0.04%
9,356
-85
-0.9% -$21.2K
INTU icon
169
Intuit
INTU
$86.3B
$2.21M 0.04%
4,513
+657
+17% +$285K
MRSH
170
Marsh
MRSH
$91.4B
$2.07M 0.04%
14,720
-916
-6% -$123K
SRCL
171
DELISTED
Stericycle Inc
SRCL
$2.04M 0.03%
28,592
-23
-0.1% -$1.69K
VNT icon
172
Vontier
VNT
$4.49B
$2.04M 0.03%
62,521
-19,464
-24% -$641K
OZK icon
173
Bank OZK
OZK
$5.57B
$2.02M 0.03%
47,875
+90
+0.2% +$3.75K
WBA
174
DELISTED
Walgreens Boots Alliance
WBA
$2.01M 0.03%
38,238
-8,865
-19% -$477K
EFA icon
175
iShares MSCI EAFE ETF
EFA
$78.5B
$1.98M 0.03%
25,128
-550
-2% -$43.7K

Similar funds

Welch & Forbes's Q2 2021 Portfolio in Review

As of Q2 2021, Welch & Forbes held 402 positions worth $5.92B, up 9.3% from $5.42B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Welch & Forbes's Q2 2021 filing shows 16 new, 142 increased, 136 reduced and 14 closed positions. Its largest new stake was KKR & Co: 20,000 shares worth $1.19M. The largest sale was Merck, an estimated $2.32M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 22% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Welch & Forbes's largest Q2 2021 buy was KKR & Co: 20,000 shares worth $1.19M.
  • Welch & Forbes added most to Amazon in Q2 2021, an estimated $6.88M increase.
  • Welch & Forbes's biggest Q2 2021 reduction was Merck, cutting an estimated $2.32M.
  • Welch & Forbes fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $1.8M.
  • Welch & Forbes's ten largest holdings make up 29% of its $5.92B portfolio in Q2 2021.
  • Welch & Forbes opened 16 new positions and closed 14 in Q2 2021.
  • Welch & Forbes's portfolio value rose 9.3% quarter-over-quarter to $5.92B.

Based on Welch & Forbes's 13F filing for Q2 2021, filed 22 Jul 2021.